Important note: Information in this article was accurate in 2000. The state of the art may have changed since the publication date.

Reuters NewMedia - Monday October 23, 2000
Maggie Fox, Health and Science Correspondent

Scientists said on Monday they had found three proteins that the human body uses to recognise and fight TB, and they are now designing a vaccine to test based on the proteins.

The researchers, at San Diego-based Epimune Inc. (NasdaqNM:EPMN - news), the University of California Los Angeles, Harvard University and elsewhere, said the vaccine approach involves a new component of the immune system not usually used in vaccinating against disease.

"In general, a lot of the vaccines that are out there are very good at inducing antibodies," Alessandro Sette, an immunologist at Epimune who worked on the study, said in a telephone interview.

Antibodies are produced by the immune system to flag invaders, such as bacteria, so other cells can clear them out. Antibody vaccines work well against viruses such as polio and smallpox.

But other bugs are trickier, and efforts to design a vaccine against hepatitis C, HIV and TB have not worked so well.

Recently, AIDS researchers have found that another component of the immune system, the killer T-cells, also known as CD8 cells or cytotoxic T-lympocytes, might be a better force to use against these tough-to-fight microbes.

The same might be true for TB, which kills three million people a year and which has resurfaced in a drug-resistant form.

Writing in the Proceedings of the National Academy of Sciences, Sette and colleagues said they used Epimmune's screening system to find proteins from the tuberculosis bacillus that would excite a CD8 response.

They chose 40 proteins and first ran them through a computer programme to identify the ones they thought were the most likely candidates.

They tested the best ones in the laboratory to see if they produced an immune system response. Three did, Sette said.

"They fit the bill of what is understood today as a meaningful response against the pathogen," he said. The three were recognised by CD8 cells taken from patients who had recovered from TB infection.

When exposed to the proteins, the CD8 cells went into killing mode, producing a compound called interferon gamma that bursts apart an infected cell to kill the invader.

Now Epimune is trying to develop a vaccine based on the proteins and organise testing of it, Sette said.

In searching for the proteins, the scientists used an approach also used by AIDS researchers -- finding people who have a natural immunity and finding just what it is about them that makes them fight the infection so well.

"What you are trying to look for are people that are recovering from infection, or the famous long-term non-progressors in HIV, or if they have hepatitis, people that have had acute hepatitis and recovered," Sette said.

001023
RE001013

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .